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Abstract
Therapeutic hypothermia, an intervention reducing core body temperature below 35 degrees Celsius,
has gained popularity in themanagement of acute brain injury after a series of small clinical trials in patients
following cardiac arrest, stroke and traumatic brain injury. This article reviews the evidence relating to
therapeutic hypothermia as an intervention in acute injury.
Introduction
Acute brain injury of any aetiology can cause sudden and
tragic loss of life or long-term disability. Acute brain
injury syndromes include traumatic brain injury, cardiac
arrest or stroke and have a considerable social and
economic consequence.
Therapeutic hypothermia, an intervention reducing core
body temperature below 35 degrees Celsius, has gained
popularity in the management of acute brain injury
following a series of small clinical trials in patients
following cardiac arrest, stroke and traumatic brain injury.
It is believed that therapeutic hypothermia provides
prophylactic neuroprotection following an ischaemic
neuronal insult. However, the evidence is generally weak
with neonatal hypoxic ischaemic encephalopathy being
the only clinical setting where there is evidence, with a low
risk of bias, in support of prophylactic neuroprotection of
therapeutic hypothermia.
Therapeutic hypothermia is not a recent concept, first
described by Fay [1] in 1945 who described cooling
patients after traumatic brain injury. Successful use of
therapeutic hypothermia after cardiac arrest in humans
was also described in the late 1950s [2,3]. However, the
use of therapeutic hypothermia did not become common
place until the 1990s, owing to the perception that
therapeutichypothermia causedmanyside effects including
pneumonia, bleeding and cardiac arrhythmias. Renewed
interest followed thepublicationofpromisingexperimental
data demonstrating that hypothermia resulted in less
neuronal damage and offered cerebral protection against
ischaemia [4-6]; thereafter, several small, single-center
clinical trials were carried out and showedpromising results
prompting the initiation of larger multicenter trials.
This article appraises the publicly available evidence
relating to therapeutic hypothermia as an intervention in
acute brain injury to date.
Theraputic hypothermia in practice
How does it work?
The goal is to improve functional outcomes through
neuroprotection of neural tissue following an acute brain
injury.
Therapeutic hypothermia is pleiotropic and potential
mechanisms by which it is believed to prevent neuronal
cell death are outlined below [7].
1. Creating a favourable balance between oxygen supply
and demand by reducing cerebral metabolic rate.
2. Preventing or reducing the disruption of the blood-
brain-barrier by reducing arteriole permeability and, as a
result, reducing the formation of cerebral oedema.
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3. Reduced free radical formation.
4. Decreased inflammatory response, including a reduc-
tion in the release of pro-inflammatory cytokines and
polymorphonuclear leukocyte adhesion in the damaged
brain.
5. Reduced seizure activity, which in turn reduces the
cerebral metabolic rate and ischaemia potential.
6. Reduced apoptosis, a common finding in all forms of
central nervous system (CNS) injury.
7. A reduction in the production of excitatory neuro-
transmitters, such as glutamate.
Methods of cooling
Cooling is often considered under the headings ‘induction’
and ‘maintenance’. Induction of hypothermia requires
careful patient preparation, including increased sedation,
focal body warming and detection and management
of shivering. Effective methods for induction of therapeu-
tic hypothermia include rapid intravenous infusion of
20-30ml/kg refrigerated 0.9% sodium chloride (inexpen-
sive) and intravascular cooling catheters or intra-nasal
nebulised perflourocarbon (Rhinochill, PhysioControl)
both of which incur significant cost.
Maintenance of hypothermia is frequently delivered by
surface cooling, with or without closed-loop feedback.
Some of these devices use reusable blankets, which are
less effective but are inexpensive, or water circulating
hydrogel heat exchange pads, which are efficient but have
an associated significant cost (approx £500/patient in the
UK). Inexpensive surface cooling with icepacks can lead
to variable temperature control with potential for
undesirable high and low temperatures and can be
labor intensive. Core cooling is achieved by the use of
intravascular catheters, which achieve rapid cooling with
reliable closed-loopmaintenance of desired temperature.
However, it involves the use of an invasive procedure and
has associated procedure- and device-specific risks.
Alternatively, extracorporeal circuits such as cardiopul-
monary bypass circuits can be used; these are quick and
effective in achieving hypothermia but are impractical in
the intensive care unit (ICU) setting and highly invasive.
It is common to use a combination of core (induction)
and surface cooling (maintenance) techniques to achieve
the desired rapid cooling and then to provide main-
tenance of hypothermia.
A third option of direct brain cooling has been suggested
as an alternative but is not yet in widespread clinical use.
Scenario
Cardiac Arrest
In animal models and clinical studies, therapeutic
hypothermia after the return of spontaneous circulation
showed improvement in functional outcome [8]. Thera-
peutic hypothermia is now recommended in several
national and international guidelines for management of
patients who have persistent coma following return of
spontaneous circulation after cardiac arrest [9-15]. The
main evidence on which these recommendations are
based comes from two publications, Bernard et al. [16]
and HACA [17] from 2002, who cooled their patients for
12-24 hours to a target temperature of 32-34 degrees
Celsius. Both studies only looked at patients who suffered
an out-of-hospital cardiac arrest where the initial rhythm
was ventricular fibrillation and the aetiology was known
to be cardiac in origin; all other aetiologies and arrhyth-
mias were excluded. However, recommendations have
been extrapolated to include all cardiac arrests where the
coma persists. Both these studies were small, suffered from
problems of heterogeneity or were at high risk of bias, yet
they are used as the rationale for instituting therapeutic
hypothermia. These data have spawned several additional
studies seeking to replicate these results in all cardiac arrests
with return of spontaneous circulation andpersistent coma;
however, this has never conclusively been demonstrated
and the risks and benefits of therapeutic hypothermia in
these settings remain unknown. The HACA and Bernard
studies [16,17] would have benefited from increased size,
blinding and from improvements in randomization in
order to reduce the risk of bias. Post-hoc analysis of the
control group of the Bernard paper showed some support
for normothermia, associated with improved outcomes –
compared with pyrexia – but therapeutic hypothermia (the
intervention) provided a significant benefit versus the
normothermic patients. Following these studies, a number
of other investigators have demonstrated significant
improvements from therapeutic hypothermia in before-
and-after studies. It is therefore plausible that therapeutic
hypothermia is of benefit inpatientswhose initial rhythm is
ventricular fibrillation, but the data do not currently exist to
support therapeutic hypothermia in cardiac arrest where
ventricular fibrillation is not the initial rhythm.
Traumatic Brain injury
The most important feature of traumatic brain injury
resuscitation is that no therapeutic intervention has
been demonstrated to improve outcome. Therapeutic
hypothermia after traumatic brain injury is often delayed
due to resuscitation, stabilisation and investigation of
the polytrauma patient who may have more immediate
treatment priorities. It is also believed that hypothermia
may be contraindicated in the multiply injured patient as
it may contribute to coagulopathy.
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To date, eight meta-analyses have been conducted to
determine the usefulness of therapeutic hypothermia in
the management of traumatic brain injury. These meta-
analyses have shown that no high-quality randomized
controlled trials have been conducted in this area as yet,
that all studies differ in their protocols and not all studies
include adequate allocation concealment and randomi-
zation [7]. A Cochrane review on therapeutic hypother-
mia in traumatic brain injury from 2009 [18] showed
that there may be therapeutic benefit in the use of
hypothermia in severe traumatic brain injury, with a
reduction in mortality and improved neurological out-
comes. However, significant benefit could only be
identified from low-quality trials and the higher quality
multicenter trials found no statistical difference in the
likelihood of death following a traumatic brain injury,
whether managed with therapeutic hypothermia or not.
All of these studies have examined the use of early (first
six hours after injury) prophylactic therapeutic hypother-
mia, delivered for neuroprotection. In clinical practice,
therapeutic hypothermia is commonly used for intracra-
nial pressure reduction, although there are no trials that
have tested this hypothesis and reported so. It has been
shown that prophylactic hypothermia reduced intracra-
nial pressure in patients with traumatic brain injury and
raised intracranial pressure, although in most cases this
was not a significant finding [7].
Stroke
Currently, the only proven treatments for ischaemic stroke
in the acute setting are thrombolysis and antiplatelet
therapy. Therapeutic hypothermia has been suggested as a
treatment modality to provide neuroprotection in this
setting, but is not considered to be an alternative to
thrombolysis, as restoration of oxygen supply to affected
areas will always provide better conditions for neuronal
recovery.However, after arterial ischemic stroke, therapeutic
hypothermia is considered as an adjunct to limit ischaemic
injury. Hypothermia has also shown benefit in animal
models of cerebral ischaemia, reducing infarct volume by
up to40%[19].Despite anumberof studies into the clinical
application of therapeutic hypothermia in acute ischaemic
stroke, none have demonstrated outcome benefit.
It is logistically challenging to provide therapeutic
hypothermia in the setting of acute ischaemic stroke;
the main challenge is that stroke patients are, in the
main, awake and do not tolerate cooling, in contrast to
cardiac arrest and traumatic brain injury patients who
have pharmacologically induced comas. The result is that
shivering increases metabolic rate and oxygen demand,
and whilst neuromuscular blockade can be used to
counteract this in the sedated/anaesthetised patient
encountered in the cardiac arrest and traumatic brain
injury settings, this is not feasible for stroke patients. This
question is the subject of the ongoing Eurohyp1 study
(http://www.eurohyp1.eu/).
Duration of hypothermia
It is generally considered to be beneficial to induce
hypothermia in as short a period of time after initial
injury as possible to provide prophylactic neuroprotec-
tion. In the cardiac arrest setting, guidelines vary
between 12 and 24 hours for duration of hypothermia
before rewarming. Neonatal hypoxic encephalopathy
cases are treated for 72 hours, and recent animal data
indicates that longer duration might be beneficial in
cardiac arrest also.
In traumatic brain injury there is a mounting body of
evidence and opinion in favour of continuing hypother-
mia for a minimum period of 48 hours [20,21]. As long
as the intracranial pressure remains high, rewarming
seems inappropriate and longer duration of hypother-
mia might be beneficial, but more data regarding these
issues, both for cardiac arrest and traumatic brain injury,
are required to give definitive advice.
Side effects
Therapeutic hypothermia is not a risk-free undertaking
and has been associated with a number of potential
adverse effects that have the potential to offset the
potential benefits. However, studies comparing thera-
peutic hypothermia with normothermia have not found
any significant difference in the incidence of severe side
effects. In order to identify and treat these complications,
patients should be cared for in specialist critical care
units. The key complications are described below.
Shivering
This is associated with an increase in sympathetic nervous
system activity and an increase in metabolic oxygen
demand, which is deleterious during the acute phase of
the patient‘s illness but has been described as a potential
predictor of a good outcome in cardiac arrest patients
and it may indeed be a biomarker for less severe cerebral
injury.
Pneumonia
The Cochrane review of 2009 [18] (traumatic brain
injury) showed that, while there was a trend towards an
increased risk of pneumonia, this was not significant.
Cardiovascular instability
Hypothermia is associated with both hypotension and
arrhythmias (mostly bradycardia). In cardiac arrested
patients, this beta blocker-like effect is possibly of
benefit [22].
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Glucose control
Hyperglycemia is common and it has been shown that
persistent hyperglycemia is associated with an increase in
mortality [22].
Electrolytes derangement
The most common electrolyte abnormality encountered is
hypokalemia; however, routine measurement of plasma
potassium, sodium andmagnesium should be undertaken.
Rebound intracranial hypertension on rewarming
This is a rise in intracranial pressure during re-warming –
a phenomenon described in many previous studies [23].
Summary
In our opinion, the case for therapeutic hypothermia
remains “unproven”with the notable exception of neonatal
hypoxic encephalopathy. There is sufficient evidence to
suggest that it may be of benefit in out-of-hospital
ventricular fibrillation cardiac arrest and this has led to its
inclusion in a number of national and international
guidelines. However, there remains doubt as to the efficacy
of therapeutic hypothermia in cardiac arrest where the
initial rhythm is not ventricular fibrillation. Currently, there
is insufficient evidence fromthepublicly available trials data
to suggest a benefit from therapeutic hypothermia in the
provision of neuroprotection or the management of raised
intracranial pressure following traumatic brain injury.
Three hypotheses need to be prospectively tested. The first
is that therapeutic hypothermia confers prophylactic
neuroprotection following traumatic brain injury. The
second is that titrated hypothermia reduces intracranial
pressure following traumatic brain injury. The third is that
therapeutic hypothermia is more effective than nor-
mothermia after cardiac arrest. The first of these is being
tested by the prophylactic hypothermia trial to lessen
traumatic brain injury randomized control trial (POLAR
RCT), the second by the Eurotherm3235trial and the third
in the Target Temperature Management after out-of-
hospital cardiac arrest (TTM study). Hopefully, the results
of these trials will provide evidence-based guidelines for
clinicians managing these clinical scenarios.
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